Share

April 10, 2018; 90 (15 Supplement) April 23, 2018

A role of GPR55 in the antiepileptic properties of cannabidiol (CBD) (P2.277)

Benjamin J. Whalley, Michael Bazelot, Evan Rosenberg, Richard Tsien
First published April 9, 2018,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 90 no. 15 Supplement P2.277
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2018.
Copyright & Usage: 
© 2018

Author Disclosures

    1. Benjamin J. Whalley1,
    2. Michael Bazelot1,2,
    3. Evan Rosenberg3 and
    4. Richard Tsien3
  1. Benjamin J. Whalley1,
  2. Michael Bazelot1,2,
  3. Evan Rosenberg3 and
  4. Richard Tsien3
  1. 1GW Research Ltd Cambridge United Kingdom
  2. 2Reading School of Pharmacy, University of Reading Cambridge United Kingdom
  3. 3Neuroscience and Physiology, NYU School of Medicine New York NY United States

Article usage

Article usage: April 2018 to April 2020

AbstractFullPdfSource
Apr 20186500Highwire
May 20184200Highwire
Jun 20182500Highwire
Jul 20183000Highwire
Aug 20183600Highwire
Sep 20183600Highwire
Oct 20186700Highwire
Nov 20185600Highwire
Dec 20183700Highwire
Jan 20195200Highwire
Feb 20194200Highwire
Mar 20193200Highwire
Apr 20193900Highwire
May 20193000Highwire
Jun 20191600Highwire
Jul 20198400Highwire
Aug 20198800Highwire
Sep 20197200Highwire
Oct 201917700Highwire
Nov 20196100Highwire
Dec 20196900Highwire
Jan 20206500Highwire
Feb 20206900Highwire
Mar 202011300Highwire
Apr 20205900Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me